Related references
Note: Only part of the references are listed.PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
IKK interacts with rictor and regulates mTORC2
Yuanfei Xu et al.
CELLULAR SIGNALLING (2013)
Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology
Venus Thomanetz et al.
JOURNAL OF CELL BIOLOGY (2013)
The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells
Akechai Im-aram et al.
PLOS ONE (2013)
Inhibition of mTOR Suppresses UVB-Induced Keratinocyte Proliferation and Survival
Theresa D. Carr et al.
CANCER PREVENTION RESEARCH (2012)
Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma
Janine G. Einspahr et al.
CANCER PREVENTION RESEARCH (2012)
Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
Asami Hagiwara et al.
CELL METABOLISM (2012)
Resveratrol-Mediated Downregulation of Rictor Attenuates Autophagic Process and Suppresses UV-Induced Skin Carcinogenesis
Jung H. Back et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2012)
Inducible raptor and rictor Knockout Mouse Embryonic Fibroblasts
Nadine Cybulski et al.
MTOR: METHODS AND PROTOCOLS (2012)
Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate
L. Allyson Checkley et al.
CANCER PREVENTION RESEARCH (2011)
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
Pat Gulhati et al.
CANCER RESEARCH (2011)
Akt signalling in health and disease
Ingeborg Hers et al.
CELLULAR SIGNALLING (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis
E. K. Kim et al.
ONCOGENE (2011)
mTOR Complex Component Rictor Interacts with PKCζ and Regulates Cancer Cell Metastasis
Fei Zhang et al.
CANCER RESEARCH (2010)
Rictor Forms a Complex with Cullin-1 to Promote SGK1 Ubiquitination and Destruction
Daming Gao et al.
MOLECULAR CELL (2010)
Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2
S-J. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
David A. Guertin et al.
CANCER CELL (2009)
mTOR complex 2 in adipose tissue negatively controls whole-body growth
Nadine Cybulski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Differential Requirement of mTOR in Postmitotic Tissues and Tumorigenesis
Caterina Nardella et al.
SCIENCE SIGNALING (2009)
Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival
Paul C. McDonald et al.
CANCER RESEARCH (2008)
Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
C. Florian Bentzinger et al.
CELL METABOLISM (2008)
Inhibition of Mammalian Target of Rapamycin by Rapamycin Causes the Regression of Carcinogen-induced Skin Tumor Lesions
Panomwat Amornphimoltham et al.
CLINICAL CANCER RESEARCH (2008)
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
Tsuneo Ikenoue et al.
EMBO JOURNAL (2008)
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
Valeria Facchinetti et al.
EMBO JOURNAL (2008)
In Vivo Analysis of Protein Kinase B (PKB)/Akt Regulation in DNA-PKcs-null Mice Reveals a Role for PKB/Akt in DNA Damage Response and Tumorigenesis
Banu Surucu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A Rictor-Myo1c complex participates in dynamic cortical actin events in 3T3-L1 adipocytes
G. Nana Hagan et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor
Janine Masri et al.
CANCER RESEARCH (2007)
Deregulated activity of akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis
Carmen Segrelles et al.
CANCER RESEARCH (2007)
P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration
Ivette Hernandez-Negrete et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Management of nonmelanoma skin cancer in 2007
Julie A. Neville et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
Zhihong Zeng et al.
BLOOD (2007)
Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth
Ville Hietakangas et al.
GENES & DEVELOPMENT (2007)
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1
David A. Guertin et al.
DEVELOPMENTAL CELL (2006)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability
Chiyo Shiota et al.
DEVELOPMENTAL CELL (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
mTOR•RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes
RC Hresko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
FOXO transcription factors at the interface between longevity and tumor suppression
EL Greer et al.
ONCOGENE (2005)
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun et al.
CANCER RESEARCH (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Stem-cell hierarchy in skin cancer
J Perez-Losada et al.
NATURE REVIEWS CANCER (2003)
Functional roles of Akt signaling in mouse skin tumorigenesis
C Segrelles et al.
ONCOGENE (2002)
Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a)
A Brunet et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)